Zhejiang Raybow Pharmaceutical Co., Ltd.

Chine

Retour au propriétaire

1-7 de 7 pour Zhejiang Raybow Pharmaceutical Co., Ltd. Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 4
        Marque 3
Juridiction
        International 5
        Europe 1
        États-Unis 1
Date
Nouveautés (dernières 4 semaines) 1
2025 décembre (MACJ) 1
2025 (AACJ) 4
Avant 2020 3
Classe IPC
C07D 223/22 - Dibenz [b, f] azépinesDibenz [b, f] azépines hydrogénées 2
A61K 31/00 - Préparations médicinales contenant des ingrédients actifs organiques 1
A61P 31/00 - Agents anti-infectieux, c.-à-d. antibiotiques, antiseptiques, chimiothérapeutiques 1
C07C 231/12 - Préparation d'amides d'acides carboxyliques par des réactions n'impliquant pas la formation de groupes carboxamide 1
C07C 67/20 - Préparation d'esters d'acides carboxyliques par conversion d'un groupe contenant de l'azote dans un groupe ester à partir d'amides ou de lactames 1
Voir plus
Classe NICE
05 - Produits pharmaceutiques, vétérinaires et hygièniques 3
39 - Services de transport, emballage et entreposage; organisation de voyages 3
42 - Services scientifiques, technologiques et industriels, recherche et conception 3
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture. 3

1.

CHEMICAL SYNTHESIS METHOD FOR 10,11-DIBROMO-5H-DIBENZO[B,F]AZEPINE-5-CARBONYL CHLORIDE

      
Numéro d'application CN2024099503
Numéro de publication 2025/245928
Statut Délivré - en vigueur
Date de dépôt 2024-06-17
Date de publication 2025-12-04
Propriétaire ZHEJIANG RAYBOW PHARMACEUTICAL CO., LTD. (Chine)
Inventeur(s)
  • Mei, Yijiang
  • Chen, Shiming
  • Xu, Zhisheng
  • Chen, Ting

Abrégé

122 may be H, C1-C6 alkoxy, etc.

Classes IPC  ?

  • C07D 223/22 - Dibenz [b, f] azépinesDibenz [b, f] azépines hydrogénées

2.

PREPARATION METHOD FOR MONOCYCLIC β-LACTAM COMPOUND

      
Numéro d'application CN2024073149
Numéro de publication 2025/152131
Statut Délivré - en vigueur
Date de dépôt 2024-01-19
Date de publication 2025-07-24
Propriétaire ZHEJIANG RAYBOW PHARMACEUTICAL CO., LTD (Chine)
Inventeur(s)
  • Xie, Zonghuan
  • Li, Qianyong
  • Liu, Yuan
  • Xu, Tinghua

Abrégé

The present invention relates to the field of pharmaceutical chemicals, and mainly relates to a preparation method for a monocyclic β-lactam compound. At present, the reaction selectivity in the prior art is not ideal, and there are problems such as high resolution difficulty and low yield. In the present invention, for constructing a target chiral center in advance, the problems that an optical isomer is difficult to separate and has low yield under the condition of small steric hindrance are solved, and because a target configuration can be directionally synthesized, the atom utilization rate is increased and industrial production is facilitated, thereby reducing environmental pollution and improving the commercial feasibility.

Classes IPC  ?

  • C07D 205/08 - Composés hétérocycliques comportant des cycles à quatre chaînons ne contenant qu'un atome d'azote comme unique hétéro-atome du cycle non condensés avec d'autres cycles comportant une liaison double entre chaînons cycliques ou entre chaînon cyclique et chaînon non cyclique avec un atome d'oxygène lié directement en position 2, p. ex. bêta-lactames
  • C07C 67/20 - Préparation d'esters d'acides carboxyliques par conversion d'un groupe contenant de l'azote dans un groupe ester à partir d'amides ou de lactames
  • A61K 31/00 - Préparations médicinales contenant des ingrédients actifs organiques
  • A61P 31/00 - Agents anti-infectieux, c.-à-d. antibiotiques, antiseptiques, chimiothérapeutiques

3.

INTERMEDIATE COMPOUND OF OXCARBAZEPINE AND PREPARATION METHOD THEREFOR

      
Numéro d'application CN2023125406
Numéro de publication 2025/039354
Statut Délivré - en vigueur
Date de dépôt 2023-10-19
Date de publication 2025-02-27
Propriétaire
  • ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (Chine)
  • ZHEJIANG RAYBOW PHARMACEUTICAL CO. LTD (Chine)
Inventeur(s)
  • Zhao, Jianhong
  • Li, Yonggang
  • Xu, Yingzhou
  • Zheng, Chenghao

Abrégé

312125544 is a C1-C6 alkyl, a substituted alkyl, an aryl, a substituted aryl, a benzyl or a substituted benzyl.

Classes IPC  ?

  • C07D 233/22 - Radicaux substitués par des atomes d'oxygène
  • C07C 231/12 - Préparation d'amides d'acides carboxyliques par des réactions n'impliquant pas la formation de groupes carboxamide

4.

SYNTHESIS METHOD FOR SUBSTITUTED IMINOSTILBENE COMPOUND

      
Numéro d'application CN2023125830
Numéro de publication 2025/030661
Statut Délivré - en vigueur
Date de dépôt 2023-10-23
Date de publication 2025-02-13
Propriétaire
  • ZHEJIANG RAYBOW PHARMACEUTICAL CO., LTD. (Chine)
  • ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (Chine)
Inventeur(s)
  • Li, Yonggang
  • Guo, Leilei
  • Zhao, Jianhong
  • Ruan, Zhenyu
  • Wang, Yineng
  • Dong, Minghao

Abrégé

The present invention provides a synthesis method for a substituted iminostilbene compound. When the substituent is hydrogen, the substituted iminostilbene compound is an iminostilbene compound and is a carbamazepine intermediate. A preparation method provided by the present invention comprises the following steps: (1) performing coupling reaction on indole and halobenzene under the action of alkali and a solvent to obtain 1-phenylindole; (2) carrying out rearrangement reaction on the 1-phenylindole under the action of a catalyst and protonic acid to obtain iminostilbene; and (3) carrying out substitution reaction on iminostilbene and chlorosulfonyl isocyanate to obtain carbamazepine. The present invention has the characteristics of high yield, short reaction time, less waste water, waste gas and solid wastes, low costs, and a simple process, and is suitable for industrial production.

Classes IPC  ?

  • C07D 223/22 - Dibenz [b, f] azépinesDibenz [b, f] azépines hydrogénées
  • C07D 209/08 - IndolesIndoles hydrogénés avec uniquement des atomes d'hydrogène ou des radicaux ne contenant que des atomes d'hydrogène et de carbone, liés directement aux atomes de carbone de l'hétérocycle

5.

Raybow PHARMACEUTICAL

      
Numéro d'application 1493522
Statut Enregistrée
Date de dépôt 2019-07-16
Date d'enregistrement 2019-07-16
Propriétaire Zhejiang Raybow Pharmaceutical Co., Ltd. (Chine)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 39 - Services de transport, emballage et entreposage; organisation de voyages
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Medical, pharmaceutical and veterinary preparations and substances as well as health care preparations; medicines for the treatment of diseases associated with the central nervous system; hypoglycemic drugs; medicines for the treatment of antiviral disorders; medicines for the treatment of tumours; cardiovascular treatment preparations; nonsteroidal anti-inflammatory drugs; anti-infectives; chemical preparations for veterinary or pharmaceutical purposes. Distribution of products in the field of pharmaceuticals, namely health care preparations in the form of pharmaceutical products, including finished products and semi-finished products for veterinary and cosmetic purposes. Pharmaceutical research (research for the discovery of new drugs); scientific research, in particular in the medical, biomedical, chemical, genetic, pharmaceutical or veterinary fields; research and development of new pharmaceutical preparations (for others); scientific research in the field of pharmacy. Medical services, veterinary services and beauty care for human beings; medical and pharmaceutical consultancy and care in the field of healthcare and pharmacy, the aforesaid services also provided via electronic networks, including the internet.

6.

RAYBOW PHARMACEUTICAL

      
Numéro de série 79270024
Statut Enregistrée
Date de dépôt 2019-07-16
Date d'enregistrement 2020-08-04
Propriétaire Zhejiang Raybow Pharmaceutical Co., Ltd. (Chine)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 39 - Services de transport, emballage et entreposage; organisation de voyages
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Medical, pharmaceutical and veterinary preparations and substances, namely, for the treatment of cancer, cardiovascular disorders, endocrinological disorders, neurological disorders, dermatological disorders, respiratory disorders; as well as health care preparations, namely, pharmaceutical preparations for the treatment of cancer, cardiovascular disorders, endocrinological disorders, neurological disorders, dermatological disorders, respiratory disorders; medicines for the treatment of diseases associated with the central nervous system; hypoglycemic drugs; medicines for the treatment of antiviral disorders; medicines for the treatment of tumors; cardiovascular treatment preparations; nonsteroidal anti-inflammatory drugs; anti-infectives; chemical preparations for veterinary or pharmaceutical purposes, namely for the treatment of cancer, cardiovascular disorders, endocrinological disorders, neurological disorders, dermatological disorders, respiratory disorders Distribution of products in the field of pharmaceuticals, namely, transportation and delivery of health care preparations in the form of pharmaceutical products, including finished products and semi-finished products for veterinary and cosmetic purposes Pharmaceutical research for the discovery of new drugs; scientific research, in particular in the medical, biomedical, chemical, genetic, pharmaceutical or veterinary fields; research and development of new pharmaceutical preparations for others; scientific research in the field of pharmacy Medical services, veterinary services; medical consultancy in the field of healthcare and dispensing of pharmaceutical preparations and pharmaceutical consultancy in the field of healthcare and dispensing of pharmaceutical preparations, the aforesaid services also provided via electronic networks, including the internet

7.

Raybow Pharmaceutical

      
Numéro d'application 018038261
Statut Enregistrée
Date de dépôt 2019-03-20
Date d'enregistrement 2019-08-23
Propriétaire Zhejiang Raybow Pharmaceutical Co., Ltd. (Chine)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 39 - Services de transport, emballage et entreposage; organisation de voyages
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Medical, pharmaceutical and veterinary preparations and substances as well as health care preparations; Medicines for the treatment of diseases associated with the central nervous system; Hypoglycemic drugs; Medicines for the treatment of antiviral disorders; Medicines for the treatment of tumours; Cardiovascular treatment preparations; Non-steroidal anti-inflammatory drugs; Anti-infectives; Chemical preparations for veterinary, food, cosmetic or pharmaceutical purposes (finished and semi-finished goods). Supply of products in the field of pharmaceuticals, namely health care preparations in the form of pharmaceutical products, including finished products and semi-finished products for veterinary and cosmetic purposes. Pharmaceutical research (research for the discovery of new drugs); Scientific research, in particular in the medical, biomedical, chemical, genetic, pharmaceutical or veterinary fields; Research and development of new pharmaceutical preparations (for others); Scientific research in the field of pharmacy. Medical services, veterinary services and beauty care for human beings; Medical and pharmaceutical consultancy and care in the field of healthcare and pharmacy, The aforesaid services also provided via electronic networks, including the Internet.